ストックスクリーナーアプリを入手
3.69
1.93%
0.07
前日終値:
$3.62
開ける：
$3.62
24時間の取引高:
30,038
Relative Volume:
0.03
時価総額：
$6.13M
収益：
$12.31M
当期純損益:
$-5.08M
株価収益率:
-3.9255
EPS:
-0.94
ネットキャッシュフロー:
$-5.20M
1週間 パフォーマンス:
-6.35%
1か月 パフォーマンス:
+25.08%
6か月 パフォーマンス:
+39.25%
1年 パフォーマンス:
-56.77%
1日の値動き範囲:
$3.57
$3.75
1週間の範囲:
$3.50
$4.15
52週間の値動き範囲:
$1.75
$9.00
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
名前
Sonoma Pharmaceuticals Inc
セクター
電話
800-759-9305
住所
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.7299 | 5.26M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
150.44 | 70.46B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.78B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.605 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.14 | 19.16B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
299.58 | 13.56B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc (SNOA) 最新ニュース
Why Alector Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser
Why Sonoma Pharmaceuticals Inc. stock attracts strong analyst attentionRapid Gain Targets - Newser
How NOEMW stock performs during market volatilityFree Risk Assessment Services - Newser
How Sonoma Pharmaceuticals Inc. stock performs during market volatilityDaily Breakout Picks - Newser
How NI Holdings Inc. stock performs during market volatilityMomentum Swing Watchlist - Newser
How Bar Harbor Bankshares stock performs during market volatilityHigh Accuracy Alerts - Newser
What makes Sonoma Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser
VOXEL(voxies) News and UpdatesCarefully Curated High Return Stocks - Newser
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
U.S. Animal Wound Care Market Size | Industry Report, 2030 - Grand View Research
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above 200 Day Moving Average – Time to Sell? - Defense World
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Is Sonoma Pharmaceuticals, Inc. technically bullish or bearish? - MarketsMojo
Global Dental Market Set to Reach USD 19.13 Bn by 2032, Driven by 7.5% CAGR | Coherent Market Insights - newstrail.com
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | SNOA Stock News - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals, Inc. SEC 10-K Report - TradingView
SONOMA PHARMACEUTICALS Earnings Preview: Recent $SNOA Insider Trading, Hedge Fund Activity, and More - Nasdaq
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Dental Market Set to Witness Robust Growth Fueled by Aesthetic - openPR.com
Keloid Treatment Market Exclusive Trends Analysis with Forecast to 2034 - openPR.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Hospital Surgical Disinfectants Market Is Booming So Rapidly - openPR.com
Williams-Sonoma, Inc. (NYSE:WSM) Given Consensus Rating of “Hold” by Analysts - Defense World
Scar Treatment Market Is Booming So Rapidly | Merz, Lumenis, Sientra - newstrail.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200-Day Moving Average – Time to Sell? - Defense World
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - Business Wire
Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer - citybiz
Keloid Treatment Market Development Accelerated by Consumer - openPR.com
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement - knoxdaily.com
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Stocks of Sonoma Pharmaceuticals Inc (SNOA) are poised to climb above their peers - Sete News
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Re - GuruFocus
Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
Financial Analysis: Integra Resources Corp (ITRG)’s Ratios Unveil Key Insights - DWinneX
Metric Deep Dive: Understanding Sonoma Pharmaceuticals Inc (SNOA) Through its Ratios - DWinneX
Analyzing SNOA’s price-to-book ratio for the last quarter - uspostnews.com
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Sonoma Pharmaceuticals Inc (SNOA) Stock: A Year of Declines and Increases - investchronicle.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX
UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock - The Globe and Mail
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Sonoma Pharmaceuticals Poised to Sell Acne Products in UK; Shares Soar Premarket - marketscreener.com
Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Sonoma Pharmaceuticals Inc (SNOA) 財務データ
収益
当期純利益
現金流量
EPS
0.08%
2.70%
大文字化:
|
ボリューム (24 時間):